296 related articles for article (PubMed ID: 27009575)
1. Genetics of FTLD: overview and what else we can expect from genetic studies.
Pottier C; Ravenscroft TA; Sanchez-Contreras M; Rademakers R
J Neurochem; 2016 Aug; 138 Suppl 1():32-53. PubMed ID: 27009575
[TBL] [Abstract][Full Text] [Related]
2. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
[TBL] [Abstract][Full Text] [Related]
3. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.
Wood EM; Falcone D; Suh E; Irwin DJ; Chen-Plotkin AS; Lee EB; Xie SX; Van Deerlin VM; Grossman M
JAMA Neurol; 2013 Nov; 70(11):1411-7. PubMed ID: 24081456
[TBL] [Abstract][Full Text] [Related]
6. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
[TBL] [Abstract][Full Text] [Related]
8. Genetic contributors to frontotemporal lobar degeneration: beyond monogenic disease.
Borroni B; Pilotto A; Bianchi M; Gilberti N; Padovani A
Mini Rev Med Chem; 2011 Oct; 11(11):988-1001. PubMed ID: 21762097
[TBL] [Abstract][Full Text] [Related]
9. [Neuropathologic Subtypes of Frontotemporal Lobar Degeneration].
Tada M; Kakita A
Brain Nerve; 2018 May; 70(5):501-516. PubMed ID: 29760288
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.
Tang SS; Li J; Tan L; Yu JT
J Alzheimers Dis; 2016 Apr; 52(4):1157-76. PubMed ID: 27104909
[TBL] [Abstract][Full Text] [Related]
11. Differences in Motor Features of
Tipton PW; Deutschlaender AB; Savica R; Heckman MG; Brushaber DE; Dickerson BC; Gavrilova RH; Geschwind DH; Ghoshal N; Graff-Radford J; Graff-Radford NR; Grossman M; Hsiung GR; Huey ED; Irwin DJ; Jones DT; Knopman DS; McGinnis SM; Rademakers R; Ramos EM; Forsberg LK; Heuer HW; Onyike C; Tartaglia C; Domoto-Reilly K; Roberson ED; Mendez MF; Litvan I; Appleby BS; Grant I; Kaufer D; Boxer AL; Rosen HJ; Boeve BF; Wszolek ZK;
Neurology; 2022 Sep; 99(11):e1154-e1167. PubMed ID: 35790423
[TBL] [Abstract][Full Text] [Related]
12. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
13. Brain perfusion patterns in familial frontotemporal lobar degeneration.
Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
[TBL] [Abstract][Full Text] [Related]
15. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
Le Ber I
Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
[TBL] [Abstract][Full Text] [Related]
16. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the genetics of the ALS-FTLD complex.
Morris HR; Waite AJ; Williams NM; Neal JW; Blake DJ
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):243-50. PubMed ID: 22477152
[TBL] [Abstract][Full Text] [Related]
18. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E
Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal Lobar Degeneration.
Premi E; Padovani A; Borroni B
Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
[TBL] [Abstract][Full Text] [Related]
20. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
